Organovo Holdings, Inc. (NASDAQ:ONVO) traded at $0.52 at last check on Monday, Jun 29, making an upward move of 8.31% on its previous day’s price.
Looking at the stock we see that its previous close was $0.48 and the beta (5Y monthly) reads 1.12 with the day’s price range being $0.4700 – 0.5500. In terms of its 52-week price range, ONVO has a high of $0.93 and a low of $0.19. The company’s stock has gained about -17.67% over that past 30 days.
On the other hand, looking at the outlook for the ONVO stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy. Long term indicators on average place the stock in the category of 100% Buy.
Based on estimates by 1 analysts where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Organovo Holdings, Inc. (ONVO) stock as a Hold, while none rate it as a Buy. None analysts rate it as outperform while none of them rated it as underperform, whereas none suggests the stock as a Sell. The stock has an overall rating of Hold and investors could take advantage and scoop up stock of the company.
Let’s briefly compare Organovo (ONVO) stock to its peers. We find that today’s price change of +8.31% and -0.59% over the past 12 months for ONVO competes that of Amgen Inc (AMGN), which has seen its stock price fall -0.55% in the latest trading session and is +25.66% over the last one year. Another of its peers Gilead Sciences Inc (GILD) has dropped -0.01% today, and is +10.36% up over the past year, while Vertex Pharmaceutic (VRTX) is also up 8.31% yet its price remains in the red at -0.59% over the same period. Amgen has a P/E ratio of 18.14 compared to Organovo’s 0 and Gilead’s 19.17. In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at 2.32% and 1.47%, respectively, in early deals.
Coming back to Organovo Holdings, Inc. (NASDAQ:ONVO), we note that the average 3-month trading volume was 1.56 Million, while that of the preceding 10-day period stands at 998.57 Million. Current shares outstanding are 130.56 Million.
According to data from Thomson Reuters, insiders hold 0.32% of the company’s shares while institutions hold 38.1%. The data shows that short shares as of June 14, 2020, stood at 1.32 Million at a short ratio of 0.64. This represents a 1.01% Short interest in Shares outstanding on June 14, 2020. Shares short dropped in June from the previous month at 2.31 Million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock +46.16% up in year-to-date price movement.